NIH-funded research R01 grant

Modulating how the brain processes thinking about others in autism with noninvasive brain stimulation

Official title: Modulating Temporoparietal Junction Mentalizing-Related Activity in Autism Spectrum Disorder using Transcranial Magnetic Stimulation

Funded at Hartford Hospital · NIH-11381809 · Data updated 2026-11-12

This project tests whether a noninvasive brain treatment (rTMS) can adjust brain activity linked to understanding others’ thoughts and feelings in adults with autism.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHartford Hospital
NIH-funded
Lab location1 site (Hartford, United States)
Project startAugust 1, 2023
Project endMay 31, 2028
Funding year2026
Award (this year)$767,568
NIH project number5R01MH132044-04
Project IDNIH-11381809 on NIH RePORTER

Who could benefit from this research

Could help

Adults 18-35 with autism spectrum disorder and IQ > 80, plus a matched typically developing control group.

Less likely to help

Adults outside the age range or with IQ below 80, or those with conditions that could interfere with MRI or TMS safety.

What this research studies

The study will compare how inhibitory versus excitatory rTMS targeting the right TPJ changes brain activity during a social mentalizing task in adults with autism compared to typically developing peers. Participants aged 18-35 with IQ above 80 will complete four study sessions, with fMRI to measure brain responses and social-communication skills. The goal is to identify whether modulating this brain region can help improve core social deficits in autism and understand the mechanism behind any changes. If successful, this could inform new, brain-based approaches to support social interaction for people with ASD.

Why it matters

Potential benefit: If successful, this work could lead to brain-based strategies to improve social understanding and communication in adults with ASD.

How similar studies have gone: Prior work shows right TPJ activity links to mentalizing and can be modulated by rTMS, supporting potential benefit but clinical impact in ASD remains to be demonstrated.

Where this research is happening

  • Hartford Hospital
    Hartford, United States
    Active

Researchers

  • Principal investigator: Assaf, Michal — Hartford Hospital
  • Study coordinator: Assaf, Michal

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.